Daito Pharmaceutical Co Ltd
TSE:4577

Watchlist Manager
Daito Pharmaceutical Co Ltd Logo
Daito Pharmaceutical Co Ltd
TSE:4577
Watchlist
Price: 2 009 JPY -0.79% Market Closed
Market Cap: 30.8B JPY
Have any thoughts about
Daito Pharmaceutical Co Ltd?
Write Note

Daito Pharmaceutical Co Ltd
Common Shares Outstanding

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Daito Pharmaceutical Co Ltd
Common Shares Outstanding Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Common Shares Outstanding CAGR 3Y CAGR 5Y CAGR 10Y
Daito Pharmaceutical Co Ltd
TSE:4577
Common Shares Outstanding
ÂĄ15.3m
CAGR 3-Years
4%
CAGR 5-Years
4%
CAGR 10-Years
2%
Takeda Pharmaceutical Co Ltd
TSE:4502
Common Shares Outstanding
ÂĄ1.6B
CAGR 3-Years
0%
CAGR 5-Years
0%
CAGR 10-Years
7%
Daiichi Sankyo Co Ltd
TSE:4568
Common Shares Outstanding
ÂĄ1.9B
CAGR 3-Years
0%
CAGR 5-Years
0%
CAGR 10-Years
10%
Otsuka Holdings Co Ltd
TSE:4578
Common Shares Outstanding
ÂĄ540.4m
CAGR 3-Years
0%
CAGR 5-Years
0%
CAGR 10-Years
0%
Chugai Pharmaceutical Co Ltd
TSE:4519
Common Shares Outstanding
ÂĄ1.6B
CAGR 3-Years
0%
CAGR 5-Years
0%
CAGR 10-Years
12%
Astellas Pharma Inc
TSE:4503
Common Shares Outstanding
ÂĄ1.8B
CAGR 3-Years
-1%
CAGR 5-Years
-1%
CAGR 10-Years
-2%
No Stocks Found

Daito Pharmaceutical Co Ltd
Glance View

Market Cap
30.7B JPY
Industry
Pharmaceuticals

Daito Pharmaceutical Co., Ltd. engages in the development, production, and sale of pharmaceutical products. The company is headquartered in Toyama-Shi, Toyama-Ken and currently employs 846 full-time employees. The company went IPO on 2010-03-24. The pharmaceutical ingredients business is engaged in the manufacture, purchase, sale and entrusted manufacture business of pharmaceutical ingredients used as raw materials for pharmaceutical manufacture and formulation. The formulation business is engaged in the manufacture, purchase, sale and entrusted manufacture business of prescription pharmaceuticals and pharmaceuticals for general-use medicines.

Intrinsic Value
2 429.67 JPY
Undervaluation 17%
Intrinsic Value
Price

See Also

What is Daito Pharmaceutical Co Ltd's Common Shares Outstanding?
Common Shares Outstanding
15.3m JPY

Based on the financial report for Aug 31, 2024, Daito Pharmaceutical Co Ltd's Common Shares Outstanding amounts to 15.3m JPY.

What is Daito Pharmaceutical Co Ltd's Common Shares Outstanding growth rate?
Common Shares Outstanding CAGR 10Y
2%

Over the last year, the Common Shares Outstanding growth was -3%. The average annual Common Shares Outstanding growth rates for Daito Pharmaceutical Co Ltd have been 4% over the past three years , 4% over the past five years , and 2% over the past ten years .

Back to Top